# Controlled Trial of Omadacycline Randomized Treatment Given for Bone and Joint Infection

> **NCT05753215** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center** · enrollment: 180 (estimated)

## Conditions studied

- Bone Infection
- Joint Infection
- Bone and Joint Infection

## Interventions

- **DRUG:** Omadacycline Pill
- **DRUG:** Standard of Care

## Key facts

- **NCT ID:** NCT05753215
- **Lead sponsor:** Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-05-09
- **Primary completion:** 2026-02
- **Final completion:** 2026-06
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2026-01-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05753215

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05753215, "Controlled Trial of Omadacycline Randomized Treatment Given for Bone and Joint Infection". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05753215. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*